World Journal of Surgical Oncology,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: Feb. 8, 2022
To
investigate
the
role
of
transmembrane
p24
trafficking
protein
2
(TMED2)
in
lung
adenocarcinoma
(LUAD)
and
determine
whether
TMED2
knockdown
could
inhibit
LUAD
vitro
vivo.TIMER2.0,
Kaplan-Meier
plotter,
gene
set
enrichment
analysis
(GSEA),
Target
Gene,
pan-cancer
systems
were
used
to
predict
potential
function
TMED2.
Western
blotting
immunohistochemistry
performed
analyze
expression
different
tissues
or
cell
lines.
The
proliferation,
development,
apoptosis
observed
using
a
lentivirus-mediated
knockdown.
Bioinformatics
western
blot
against
inflammation
via
TLR4/NF-κB
signaling
pathway
conducted.TMED2
tumor
was
higher
than
that
normal
positively
correlated
with
poor
survival
cancer
negatively
LUAD.
tumors
HCC827
cells.
inhibited
development
vivo
increased
levels
inflammatory
factors
pathway.
TME,
immune
score,
TME-associated
cells,
their
target
markers,
some
mechanisms
pathways,
as
determined
TIMER2.0,
GO,
KEGG
assays.TMED2
may
regulate
through
enhance
prognosis
by
regulating
inflammation,
which
provide
new
strategy
for
treating
inflammation.
Cell Death and Disease,
Journal Year:
2024,
Volume and Issue:
15(3)
Published: March 8, 2024
Abstract
Cancer
metabolism
mainly
includes
carbohydrate,
amino
acid
and
lipid
metabolism,
each
of
which
can
be
reprogrammed.
These
processes
interact
with
other
to
adapt
the
complicated
microenvironment.
Ferroptosis
is
a
regulated
cell
death
induced
by
iron-dependent
peroxidation,
morphologically
different
from
apoptosis,
necrosis,
necroptosis,
pyroptosis,
autophagy-dependent
cuprotosis.
plays
opposite
roles
in
ferroptosis.
On
one
hand,
carbohydrate
produce
NADPH
maintain
GPX4
FSP1
function,
provide
substrates
for
synthesizing
GPX4;
on
might
synthesize
PUFAs
trigger
The
mechanisms
through
cancer
affects
ferroptosis
have
been
investigated
extensively
long
time;
however,
some
not
yet
elucidated.
In
this
review,
we
summarize
interaction
between
Importantly,
were
most
concerned
how
these
targets
utilized
therapy.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(24), P. 13335 - 13335
Published: Dec. 11, 2021
As
a
main
subtype
of
lung
cancer,
the
current
situation
non-small
cell
cancer
(NSCLC)
remains
severe
worldwide
with
19%
survival
rate
at
5
years.
conventional
therapy
approaches,
such
as
chemotherapy,
radiotherapy,
targeted
therapy,
and
immunotherapy,
gradually
develop
into
resistance,
searching
for
novel
therapeutic
strategy
NSCLC
is
urgent.
Ferroptosis,
an
iron-dependent
programmed
necrosis,
has
now
been
widely
considered
key
factor
affecting
tumorigenesis
progression
in
various
cancers.
Focusing
on
its
effect
NSCLC,
different
situations,
ferroptosis
can
be
triggered
or
restrained.
When
was
induced
it
available
to
inhibit
tumor
both
vitro
vivo.
The
dominating
mechanism
due
regulation
classic
ferroptosis-repressed
GSH-dependent
GPX4
signaling
pathway
instead
other
fractional
regulating
signal
axes
that
regulated
via
impacting
ROS,
cellular
iron
levels,
etc.
In
terms
prevention
GSH-independent
also
discovered,
interestingly
exhibiting
same
upstream
signaling.
addition,
this
review
summarizes
elaborates
their
association
specific
mechanisms
through
bioinformatics
analysis
multiple
experimental
evidence
from
cascades.
Finally,
points
out
possibility
working
resistance
emphasizing
potential.
International Journal of Cancer,
Journal Year:
2023,
Volume and Issue:
153(5), P. 918 - 931
Published: Feb. 27, 2023
Abstract
Oncogene‐induced
hyper‐proliferation
in
cancer
cells
is
accompanied
by
the
onset
of
different
stresses,
including
DNA‐replication
stress,
metabolic
stress
and
oxidative
stress.
Excessive
accumulation
reactive
oxygen
species
(ROS)
plays
a
pivotal
contradictory
role
tumor
progression.
ROS
dictates
multitude
cell
signaling
pathways
to
facilitate
malignant
transformation
cells.
In
meantime,
burden
mandates
reinforcing
antioxidant
capacity
mitigate
detrimental
damages.
The
addiction
increased
iron
demands
also
impinges
on
sensitivity
ferroptosis.
Targeting
redox
homeostasis
ferroptosis
overcome
drug
resistance
treatment
has
become
an
attractive
research
topic.
However,
roles
oncogenic
regulation
have
not
been
comprehensively
discussed.
this
review,
we
summarize
current
knowledge
regarding
interplay
between
context
biology.
We
emphasize
implication
regulation.
provide
overview
strategies
targeting
treatment.
Frontiers in Cell and Developmental Biology,
Journal Year:
2022,
Volume and Issue:
9
Published: Jan. 24, 2022
Background:
Lung
adenocarcinoma
(LUAD),
the
most
common
subtype
of
non-small
cell
lung
cancer
(NSCLC),
is
associated
with
poor
prognosis.
However,
current
stage-based
clinical
methods
are
insufficient
for
survival
prediction
and
decision-making.
This
study
aimed
to
establish
a
novel
model
evaluating
risk
LUAD
based
on
hypoxia,
immunity,
epithelial-mesenchymal
transition
(EMT)
gene
signatures.
Methods:
In
this
study,
we
used
data
from
TCGA-LUAD
training
cohort
GSE68465
GSE72094
validation
cohorts.
Immunotherapy
datasets
GSE135222,
GSE126044,
IMvigor210
were
obtained
previous
study.
Using
bioinformatic
machine
algorithms,
established
immune,
EMT
signatures,
which
was
then
divide
patients
into
high
low
groups.
We
analyzed
differences
in
enriched
pathways
between
two
groups,
following
investigated
whether
score
correlated
stemness
scores,
genes
related
m6A,
m5C,
m1A
m7G
modification,
immune
microenvironment,
immunotherapy
response,
multiple
anti-cancer
drug
sensitivity.
Results:
Overall
differed
significantly
high-risk
low-risk
groups
(HR
=
4.26).
The
AUCs
predicting
1-,
3-,
5-year
0.763,
0.766,
0.728,
respectively.
dataset,
HR
2.03,
while
0.69,
0.651,
0.618,
corresponding
values
dataset
an
2.36
0.653,
0.662,
0.749,
could
independently
predict
OS
LUAD,
highly
scores
numerous
modification-related
genes.
Furthermore,
microenvironment
characteristics.
GSE135222
4.26
AUC
0.702.
Evaluation
GSE126044
cohorts
indicated
that
PD-1/PD-LI
inhibitor
treatment
may
be
therapy
various
drugs
scores.
Conclusion:
Our
developed
signatures
can
aid
prognosis
guiding
LUAD.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Jan. 4, 2024
Abstract
Lung
adenocarcinoma
(LUAD)
is
a
malignant
tumor
with
high
lethality,
and
the
aim
of
this
study
was
to
identify
promising
biomarkers
for
LUAD.
Using
TCGA-LUAD
dataset
as
discovery
cohort,
novel
joint
framework
VAEjMLP
based
on
variational
autoencoder
(VAE)
multilayer
perceptron
(MLP)
proposed.
And
Shapley
Additive
Explanations
(SHAP)
method
introduced
evaluate
contribution
feature
genes
classification
decision,
which
helped
us
develop
biologically
meaningful
biomarker
potential
scoring
algorithm.
Nineteen
LUAD
were
identified,
involved
in
regulation
immune
metabolic
functions
A
prognostic
risk
model
constructed
by
HLA-DRB1,
SCGB1A1,
HLA-DRB5
screened
Cox
regression
analysis,
dividing
patients
into
high-risk
low-risk
groups.
The
validated
external
datasets.
group
characterized
enrichment
pathways
higher
infiltration
compared
group.
While,
accompanied
an
increase
pathway
activity.
There
significant
differences
between
high-
groups
reprogramming
aerobic
glycolysis,
amino
acids,
lipids,
well
angiogenic
activity,
epithelial-mesenchymal
transition,
tumorigenic
cytokines,
inflammatory
response.
Furthermore,
more
sensitive
Afatinib,
Gefitinib,
Gemcitabine
predicted
pRRophetic
This
provides
signatures
capable
revealing
landscapes
LUAD,
may
shed
light
identification
other
cancer
biomarkers.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
173, P. 116356 - 116356
Published: Feb. 29, 2024
Aging,
an
inevitable
aspect
of
human
existence,
serves
as
one
the
predominant
risk
factors
for
vascular
diseases.
Delving
into
mystery
disease's
pathophysiology,
profound
involvement
programmed
cell
death
(PCD)
has
been
extensively
demonstrated.
PCD
is
a
fundamental
biological
process
that
plays
crucial
role
in
both
normal
physiology
and
pathology,
including
recently
discovered
form,
ferroptosis.
Ferroptosis
characterized
by
its
reliance
on
iron
lipid
peroxidation,
significant
disease
pathophysiology
increasingly
acknowledged.
This
phenomenon
not
only
offers
promising
therapeutic
target
but
also
deepens
our
understanding
complex
relationship
between
ferroptosis
age-related
Consequently,
this
article
aims
to
thoroughly
review
mechanisms
enable
effective
control
inhibition
It
focuses
genetic
pharmacological
interventions,
with
goal
developing
innovative
strategies
combat
Frontiers in Genetics,
Journal Year:
2022,
Volume and Issue:
12
Published: Jan. 3, 2022
Ferroptosis
is
associated
with
the
prognosis
and
therapeutic
responses
of
patients
various
cancers.
LncRNAs
are
reported
to
exhibit
antitumor
or
oncogenic
functions.
Currently,
few
studies
have
assessed
combined
effects
ferroptosis
lncRNAs
on
therapy
stomach
cancer.
In
this
study,
transcriptomic
clinical
data
were
downloaded
from
TCGA
database,
ferroptosis-related
genes
obtained
FerrDb
database.
Through
correlation
analysis,
Cox
Lasso
algorithm,
10
prognostic
(AC009299.2,
AC012020.1,
AC092723.2,
AC093642.1,
AC243829.4,
AL121748.1,
FLNB-AS1,
LINC01614,
LINC02485,
LINC02728)
screened
construct
a
model,
which
was
verified
in
two
test
cohorts.
Risk
scores
for
cancer
calculated,
divided
into
risk
groups.
The
low-risk
group,
based
median
value,
had
longer
overall
survival
time
KM
curve,
lower
proportion
dead
distribution
curve.
Potential
mechanisms
possible
functions
revealed
using
GSEA
ceRNA
network.
By
integrating
information,
association
between
features
analyzed
several
affecting
identified.
Then,
nomogram
developed
predict
rates,
its
good
predictive
performance
indicated
by
relatively
high
C-index
(0.67118161)
match
calibration
curves.
Next,
these
explored.
Patients
group
an
immune-activating
environment,
higher
immune
scores,
TMB,
TIDE
expression
checkpoints,
suggesting
they
might
receive
greater
benefit
checkpoint
inhibitor
therapy.
addition,
significant
difference
sensitivity
mitomycin.
C,
cisplatin,
docetaxel,
but
not
etoposide
paclitaxel,
observed.
summary,
model
guiding
significance
personalized
It
helped
screen
who
immunotherapy
guided
selection
chemotherapeutic
drugs.